Governance & AdministrationGovernance
UCLA CTSI has a flexible and responsive governance structure. CTSI Director Steven M. Dubinett, MD chairs the Executive Oversight Committee (EOC), CTSI's policy-making body. Program leaders, CTSI associate directors and the leader of the CTSI Maternal, Child and Adolescent Health Committee sit on the EOC.
Dr. Dubinett reports to UCLA Chancellor Gene Block, He is advised by Internal and External Advisory Boards, both of which meet twice yearly. UCLA CTSI as a whole reports to the National Center for Advancing Translational Science (NCATS), part of the National Institutes of Health. NCATS awarded UCLA CTSI a five-year, $81.3-million grant in June, 2011. CTSI makes an annual progress report to NCATS.
CTSI's day-to-day operations are carried out by its nine program areas, the Maternal, Child and Adolescent Health Committee, and the Office of the Institute, which houses CTSI's administrative, budgetary, communications and program evaluation functions. The programs and the Office of the Institute report to Dr. Dubinett.
- UCLA CTSI Leadership
- Internal and External Advisory Boards
- CTSI Programs
- National Center for Advancing Translational Science
- UC BRAID
UCLA, along with 4 other UC medical campuses - in collaboration with the UC Office of the President (UCOP) - have identified system-wide collaboration in biomedical research as an opportunity to enhance clinical and translational research efforts. In response, they launched an initiative in 2010 to identify policy changes and areas of collaboration to accelerate biomedical research across the UC biomedical campuses. The UC Biomedical Research Acceleration, Integration and Development (UC BRAID) program, is this effort to accelerate clinical and translational research.
UC BRAID involvement:
- UCReX (enables UC investigators to identify potential research study cohorts at the five UC medical centers)
- Engage UC (co-led by investigators at UCSF and UCLA; develops policies about the management of leftover blood and tissue samples collected for research, creates community-guided governance for biobanks across the 5 University of California medical campuses; and redesigns the process of asking patient permission for research use of leftover biological samples, including research using genetic information)